Drug Type Recombinant protein, Enzyme |
Synonyms Recombinant human hyaluronidase(Kangju Biotechnology), KJ 017, KJ017 |
Target |
Action modulators |
Mechanism Hyaluronic acid modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Drug adjuvant | NDA/BLA | China | 15 Jul 2024 |
Not Applicable | Vitreus disorder NOS Adjuvant | - | Hilenex® (human recombinant hyaluronidase) | phlganvsdz(ntzscsuulf) = yomcxbhsug yesmagftqi (cdjadacgga ) View more | - | 01 Apr 2014 | |
human recombinant hyaluronidase (Control (no treatment)) | phlganvsdz(ntzscsuulf) = elnsqnzkiw yesmagftqi (cdjadacgga ) View more |